Novel motif:146: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif146_AGACGAAGA
|novel_motifs_human_sample_pval=11376-118A8_11051;0.850127,11327-117E4_11969;0.694024,11473-119C6_11054;0.998032,11474-119C7_12067;0.7...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:20, 9 September 2013
name: | motif146_AGACGAAGA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0040040 | thermosensory behavior | 7.769053e-10 |
GO:0071460 | cellular response to cell-matrix adhesion | 1.933177e-9 |
GO:0033693 | neurofilament bundle assembly | 3.606949e-9 |
GO:0045104 | intermediate filament cytoskeleton organization | 1.175122e-8 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 1.743392e-8 |
GO:2000098 | negative regulation of smooth muscle cell-matrix adhesion | 3.703342e-8 |
GO:0071258 | cellular response to gravity | 3.703342e-8 |
GO:0061044 | negative regulation of vascular wound healing | 3.703342e-8 |
GO:0035491 | positive regulation of leukotriene production involved in inflammatory response | 3.703342e-8 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 6.525563e-8 |
GO:0051549 | positive regulation of keratinocyte migration | 6.753030e-8 |
GO:0008090 | retrograde axon cargo transport | 8.699165e-8 |
GO:2000369 | regulation of clathrin-mediated endocytosis | 8.706219e-8 |
GO:0045103 | intermediate filament-based process | 1.237784e-7 |
GO:0002439 | chronic inflammatory response to antigenic stimulus | 1.488208e-7 |
GO:0033629 | negative regulation of cell adhesion mediated by integrin | 1.583004e-7 |
GO:0032800 | receptor biosynthetic process | 1.652340e-7 |
GO:0015827 | tryptophan transport | 2.203822e-7 |
GO:0030730 | sequestering of triglyceride | 2.849409e-7 |
GO:0008211 | glucocorticoid metabolic process | 2.982716e-7 |
GO:0050829 | defense response to Gram-negative bacterium | 3.372630e-7 |
GO:0006412 | translation | 3.632783e-7 |
GO:0045109 | intermediate filament organization | 3.931510e-7 |
GO:0010467 | gene expression | 6.560010e-7 |
GO:0008089 | anterograde axon cargo transport | 6.984152e-7 |
GO:2000097 | regulation of smooth muscle cell-matrix adhesion | 7.647550e-7 |
GO:2000370 | positive regulation of clathrin-mediated endocytosis | 9.469613e-7 |
GO:0000726 | non-recombinational repair | 9.604712e-7 |
GO:0042574 | retinal metabolic process | 1.065141e-6 |
GO:0044140 | negative regulation of growth of symbiont on or near host surface | 1.253987e-6 |
GO:0060559 | positive regulation of calcidiol 1-monooxygenase activity | 1.513563e-6 |
GO:0060075 | regulation of resting membrane potential | 1.748624e-6 |
GO:0010608 | posttranscriptional regulation of gene expression | 2.227217e-6 |
GO:0051533 | positive regulation of NFAT protein import into nucleus | 2.610855e-6 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 2.816301e-6 |
GO:0060052 | neurofilament cytoskeleton organization | 3.306439e-6 |
GO:0019087 | transformation of host cell by virus | 3.315655e-6 |
GO:0006726 | eye pigment biosynthetic process | 3.340087e-6 |
GO:0000712 | resolution of meiotic recombination intermediates | 3.378504e-6 |
GO:0045110 | intermediate filament bundle assembly | 3.794775e-6 |
GO:0070587 | regulation of cell-cell adhesion involved in gastrulation | 3.920874e-6 |
GO:0034114 | regulation of heterotypic cell-cell adhesion | 3.920874e-6 |
GO:0015801 | aromatic amino acid transport | 4.414763e-6 |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 4.586307e-6 |
GO:0032642 | regulation of chemokine production | 4.700936e-6 |
GO:0010624 | regulation of Schwann cell proliferation | 5.452266e-6 |
GO:0042035 | regulation of cytokine biosynthetic process | 5.564316e-6 |
GO:0043243 | positive regulation of protein complex disassembly | 7.008140e-6 |
GO:0032757 | positive regulation of interleukin-8 production | 7.735591e-6 |
GO:0016032 | viral reproduction | 7.923745e-6 |
GO:0002437 | inflammatory response to antigenic stimulus | 8.352058e-6 |
GO:0071803 | positive regulation of podosome assembly | 8.435328e-6 |
GO:0006417 | regulation of translation | 9.259124e-6 |
GO:0071316 | cellular response to nicotine | 9.639813e-6 |
GO:0071219 | cellular response to molecule of bacterial origin | 9.690204e-6 |
GO:0060988 | lipid tube assembly | 1.111296e-5 |
GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response | 1.174645e-5 |
GO:0060558 | regulation of calcidiol 1-monooxygenase activity | 1.177170e-5 |
GO:0019896 | axon transport of mitochondrion | 1.185560e-5 |
GO:0043616 | keratinocyte proliferation | 1.411612e-5 |
GO:0045672 | positive regulation of osteoclast differentiation | 1.592142e-5 |
GO:0060603 | mammary gland duct morphogenesis | 1.778929e-5 |
GO:0032793 | positive regulation of CREB transcription factor activity | 1.823047e-5 |
GO:0016226 | iron-sulfur cluster assembly | 1.882437e-5 |
GO:0045408 | regulation of interleukin-6 biosynthetic process | 1.948749e-5 |
GO:0032645 | regulation of granulocyte macrophage colony-stimulating factor production | 2.004369e-5 |
GO:0018283 | iron incorporation into metallo-sulfur cluster | 2.116123e-5 |
GO:0071216 | cellular response to biotic stimulus | 2.358572e-5 |
GO:0060745 | mammary gland branching involved in pregnancy | 2.518046e-5 |
GO:0070340 | detection of bacterial lipopeptide | 2.663934e-5 |
GO:0044003 | modification by symbiont of host morphology or physiology | 2.734239e-5 |
GO:0015919 | peroxisomal membrane transport | 2.914600e-5 |
GO:0060751 | branch elongation involved in mammary gland duct branching | 3.031663e-5 |
GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation | 3.126644e-5 |
GO:0019047 | provirus integration | 3.297403e-5 |
GO:0048193 | Golgi vesicle transport | 3.508917e-5 |
GO:0032677 | regulation of interleukin-8 production | 3.638184e-5 |
GO:0006398 | histone mRNA 3'-end processing | 3.679155e-5 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 3.703593e-5 |
GO:0006369 | termination of RNA polymerase II transcription | 4.066055e-5 |
GO:0009948 | anterior/posterior axis specification | 4.147686e-5 |
GO:0090304 | nucleic acid metabolic process | 4.224369e-5 |
GO:0008088 | axon cargo transport | 4.236360e-5 |
GO:0045073 | regulation of chemokine biosynthetic process | 4.983804e-5 |
GO:0046732 | active induction of host immune response by virus | 5.094581e-5 |
GO:0071222 | cellular response to lipopolysaccharide | 5.110613e-5 |
GO:0060557 | positive regulation of vitamin D biosynthetic process | 5.113269e-5 |
GO:0045084 | positive regulation of interleukin-12 biosynthetic process | 5.522498e-5 |
GO:0051208 | sequestering of calcium ion | 5.627959e-5 |
GO:0007021 | tubulin complex assembly | 5.737156e-5 |
GO:0009880 | embryonic pattern specification | 6.054809e-5 |
GO:0050901 | leukocyte tethering or rolling | 6.117446e-5 |
GO:0030225 | macrophage differentiation | 6.178174e-5 |
GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 6.219901e-5 |
GO:0071283 | cellular response to iron(III) ion | 6.619250e-5 |
GO:0060623 | regulation of chromosome condensation | 6.619250e-5 |
GO:0046680 | response to DDT | 6.619250e-5 |
GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 6.619250e-5 |
GO:0045994 | positive regulation of translational initiation by iron | 6.793056e-5 |
GO:0002037 | negative regulation of L-glutamate transport | 6.793056e-5 |
GO:0032490 | detection of molecule of bacterial origin | 6.869518e-5 |
GO:0032722 | positive regulation of chemokine production | 7.168045e-5 |
GO:0010625 | positive regulation of Schwann cell proliferation | 7.321461e-5 |
GO:0052509 | positive regulation by symbiont of host defense response | 7.916983e-5 |
GO:0006438 | valyl-tRNA aminoacylation | 8.062105e-5 |
GO:0070265 | necrotic cell death | 8.523537e-5 |
GO:0046687 | response to chromate | 8.848302e-5 |
GO:0033986 | response to methanol | 8.848302e-5 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 8.852508e-5 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 1.006392e-4 |
GO:0001659 | temperature homeostasis | 1.028524e-4 |
GO:0033617 | mitochondrial respiratory chain complex IV assembly | 1.163081e-4 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 1.174666e-4 |
GO:0060556 | regulation of vitamin D biosynthetic process | 1.179601e-4 |
GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.229352e-4 |
GO:0006418 | tRNA aminoacylation for protein translation | 1.237877e-4 |
GO:0015824 | proline transport | 1.302006e-4 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 1.320993e-4 |
GO:0009059 | macromolecule biosynthetic process | 1.329079e-4 |
GO:0050729 | positive regulation of inflammatory response | 1.344381e-4 |
GO:0045410 | positive regulation of interleukin-6 biosynthetic process | 1.347106e-4 |
GO:0002765 | immune response-inhibiting signal transduction | 1.381421e-4 |
GO:0009755 | hormone-mediated signaling pathway | 1.415325e-4 |
GO:0016070 | RNA metabolic process | 1.436441e-4 |
GO:0009636 | response to toxin | 1.479896e-4 |
GO:0050715 | positive regulation of cytokine secretion | 1.517614e-4 |
GO:0071727 | cellular response to triacyl bacterial lipopeptide | 1.525457e-4 |
GO:0042495 | detection of triacyl bacterial lipopeptide | 1.525457e-4 |
GO:0006447 | regulation of translational initiation by iron | 1.537955e-4 |
GO:0050714 | positive regulation of protein secretion | 1.666901e-4 |
GO:0051650 | establishment of vesicle localization | 1.724133e-4 |
GO:0002573 | myeloid leukocyte differentiation | 1.747001e-4 |
GO:2000617 | positive regulation of histone H3-K9 acetylation | 1.816012e-4 |
GO:2000620 | positive regulation of histone H4-K16 acetylation | 1.816012e-4 |
GO:0070625 | zymogen granule exocytosis | 1.816012e-4 |
GO:0070512 | positive regulation of histone H4-K20 methylation | 1.816012e-4 |
GO:0000185 | activation of MAPKKK activity | 1.906960e-4 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.967537e-4 |
GO:0016046 | detection of fungus | 1.967537e-4 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 1.967537e-4 |
GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production | 2.067672e-4 |
GO:0019048 | virus-host interaction | 2.105442e-4 |
GO:0060322 | head development | 2.377758e-4 |
GO:0034645 | cellular macromolecule biosynthetic process | 2.408644e-4 |
GO:0051099 | positive regulation of binding | 2.412880e-4 |
GO:0031622 | positive regulation of fever generation | 2.478999e-4 |
GO:0031124 | mRNA 3'-end processing | 2.508129e-4 |
GO:0031293 | membrane protein intracellular domain proteolysis | 2.518594e-4 |
GO:0045670 | regulation of osteoclast differentiation | 2.551767e-4 |
GO:0071637 | regulation of monocyte chemotactic protein-1 production | 2.700568e-4 |
GO:0072668 | tubulin complex biogenesis | 2.743004e-4 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 2.743004e-4 |
GO:0022415 | viral reproductive process | 2.810957e-4 |
GO:0003012 | muscle system process | 2.957292e-4 |
GO:0014805 | smooth muscle adaptation | 3.113602e-4 |
GO:0043279 | response to alkaloid | 3.266577e-4 |
GO:0045948 | positive regulation of translational initiation | 3.324483e-4 |
GO:0000226 | microtubule cytoskeleton organization | 3.501867e-4 |
GO:0043500 | muscle adaptation | 3.531656e-4 |
GO:0009107 | lipoate biosynthetic process | 3.548119e-4 |
GO:0034754 | cellular hormone metabolic process | 3.602310e-4 |
GO:0046730 | induction of host immune response by virus | 3.643048e-4 |
GO:0042487 | regulation of odontogenesis of dentine-containing tooth | 3.643048e-4 |
GO:0032675 | regulation of interleukin-6 production | 3.661227e-4 |
GO:0035767 | endothelial cell chemotaxis | 3.687860e-4 |
GO:0090232 | positive regulation of spindle checkpoint | 3.789007e-4 |
GO:0042987 | amyloid precursor protein catabolic process | 3.892499e-4 |
GO:0043148 | mitotic spindle stabilization | 3.928663e-4 |
GO:0002036 | regulation of L-glutamate transport | 4.119248e-4 |
GO:0050908 | detection of light stimulus involved in visual perception | 4.186192e-4 |
GO:2000615 | regulation of histone H3-K9 acetylation | 4.264048e-4 |
GO:0003009 | skeletal muscle contraction | 4.291960e-4 |
GO:0010829 | negative regulation of glucose transport | 4.314681e-4 |
GO:0006422 | aspartyl-tRNA aminoacylation | 4.433024e-4 |
GO:0090196 | regulation of chemokine secretion | 4.666384e-4 |
GO:0015804 | neutral amino acid transport | 4.739573e-4 |
GO:0002237 | response to molecule of bacterial origin | 4.760340e-4 |
GO:0014912 | negative regulation of smooth muscle cell migration | 4.774823e-4 |
GO:0050885 | neuromuscular process controlling balance | 4.805364e-4 |
GO:0001300 | chronological cell aging | 4.805561e-4 |
GO:0006903 | vesicle targeting | 4.862097e-4 |
GO:0001817 | regulation of cytokine production | 4.958711e-4 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 4.965569e-4 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 4.970886e-4 |
GO:0030574 | collagen catabolic process | 5.232828e-4 |
GO:0051956 | negative regulation of amino acid transport | 5.234730e-4 |
GO:0060251 | regulation of glial cell proliferation | 5.314618e-4 |
GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway | 5.332322e-4 |
GO:0072285 | mesenchymal to epithelial transition involved in metanephric renal vesicle formation | 5.332322e-4 |
GO:0060248 | detection of cell density by contact stimulus involved in contact inhibition | 5.332322e-4 |
GO:0007371 | ventral midline determination | 5.332322e-4 |
GO:0015696 | ammonium transport | 5.353453e-4 |
GO:0015680 | intracellular copper ion transport | 5.376058e-4 |
GO:0014038 | regulation of Schwann cell differentiation | 5.482369e-4 |
GO:0000375 | RNA splicing, via transesterification reactions | 5.549745e-4 |
GO:0031652 | positive regulation of heat generation | 5.573797e-4 |
GO:0032680 | regulation of tumor necrosis factor production | 5.581715e-4 |
GO:0034014 | response to triglyceride | 5.589153e-4 |
GO:0042108 | positive regulation of cytokine biosynthetic process | 5.632699e-4 |
GO:0050905 | neuromuscular process | 5.699296e-4 |
GO:0061043 | regulation of vascular wound healing | 5.804452e-4 |
GO:0032496 | response to lipopolysaccharide | 5.888326e-4 |
GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin | 6.005765e-4 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 6.099732e-4 |
GO:0033590 | response to cobalamin | 6.141916e-4 |
GO:0006117 | acetaldehyde metabolic process | 6.141916e-4 |
GO:0019227 | neuronal action potential propagation | 6.235204e-4 |
GO:0035553 | oxidative single-stranded RNA demethylation | 6.358323e-4 |
GO:0031644 | regulation of neurological system process | 6.642324e-4 |
GO:0051984 | positive regulation of chromosome segregation | 6.643746e-4 |
GO:0001660 | fever generation | 6.675000e-4 |
GO:0051457 | maintenance of protein location in nucleus | 6.942713e-4 |
GO:0060020 | Bergmann glial cell differentiation | 7.016887e-4 |
GO:0032729 | positive regulation of interferon-gamma production | 7.064133e-4 |
GO:0051235 | maintenance of location | 7.282561e-4 |
GO:0034339 | regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 7.374946e-4 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 7.672195e-4 |
GO:0045080 | positive regulation of chemokine biosynthetic process | 7.748380e-4 |
GO:0010817 | regulation of hormone levels | 7.856235e-4 |
GO:0051257 | spindle midzone assembly involved in meiosis | 7.896296e-4 |
GO:0007060 | male meiosis chromosome segregation | 7.896296e-4 |
GO:0030302 | deoxynucleotide transport | 7.896296e-4 |
GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process | 7.949440e-4 |
GO:0051817 | modification of morphology or physiology of other organism involved in symbiotic interaction | 7.989453e-4 |
GO:0010034 | response to acetate | 8.228021e-4 |
GO:2000193 | positive regulation of fatty acid transport | 8.292257e-4 |
GO:0019915 | lipid storage | 8.475988e-4 |
GO:0032755 | positive regulation of interleukin-6 production | 8.516398e-4 |
GO:0072595 | maintenance of protein localization to organelle | 8.583121e-4 |
GO:0006352 | transcription initiation, DNA-dependent | 8.712197e-4 |
GO:0070988 | demethylation | 9.320339e-4 |
GO:0045870 | positive regulation of retroviral genome replication | 1.061184e-3 |
GO:0003094 | glomerular filtration | 1.061184e-3 |
GO:0002537 | nitric oxide production involved in inflammatory response | 1.086235e-3 |
GO:0048385 | regulation of retinoic acid receptor signaling pathway | 1.091686e-3 |
GO:0033687 | osteoblast proliferation | 1.108619e-3 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 1.120051e-3 |
GO:0050707 | regulation of cytokine secretion | 1.126428e-3 |
GO:0019059 | initiation of viral infection | 1.135433e-3 |
GO:0042482 | positive regulation of odontogenesis | 1.147784e-3 |
GO:0055093 | response to hyperoxia | 1.158884e-3 |
GO:0014040 | positive regulation of Schwann cell differentiation | 1.161863e-3 |
GO:0051701 | interaction with host | 1.167449e-3 |
GO:0006936 | muscle contraction | 1.168152e-3 |
GO:0021612 | facial nerve structural organization | 1.180322e-3 |
GO:0071639 | positive regulation of monocyte chemotactic protein-1 production | 1.183933e-3 |
GO:0042036 | negative regulation of cytokine biosynthetic process | 1.192969e-3 |
GO:0019233 | sensory perception of pain | 1.197904e-3 |
GO:0009408 | response to heat | 1.203252e-3 |
GO:0021532 | neural tube patterning | 1.232519e-3 |
GO:0090197 | positive regulation of chemokine secretion | 1.263672e-3 |
GO:0050727 | regulation of inflammatory response | 1.270416e-3 |
GO:0060252 | positive regulation of glial cell proliferation | 1.298657e-3 |
GO:0060324 | face development | 1.351474e-3 |
GO:0035584 | calcium-mediated signaling using intracellular calcium source | 1.409358e-3 |
GO:0014048 | regulation of glutamate secretion | 1.441301e-3 |
GO:0070164 | negative regulation of adiponectin secretion | 1.448008e-3 |
GO:0060355 | positive regulation of cell adhesion molecule production | 1.448008e-3 |
GO:0035505 | positive regulation of myosin light chain kinase activity | 1.448008e-3 |
GO:0032308 | positive regulation of prostaglandin secretion | 1.464803e-3 |
GO:0042445 | hormone metabolic process | 1.464869e-3 |
GO:0031081 | nuclear pore distribution | 1.467312e-3 |
GO:0019058 | viral infectious cycle | 1.518833e-3 |
GO:0042508 | tyrosine phosphorylation of Stat1 protein | 1.522648e-3 |
GO:0045124 | regulation of bone resorption | 1.526095e-3 |
GO:0015808 | L-alanine transport | 1.538163e-3 |
GO:0033127 | regulation of histone phosphorylation | 1.544647e-3 |
GO:0051293 | establishment of spindle localization | 1.583671e-3 |
GO:0031123 | RNA 3'-end processing | 1.585337e-3 |
GO:0007389 | pattern specification process | 1.592118e-3 |
GO:0060555 | induction of necroptosis by extracellular signals | 1.606201e-3 |
GO:0071726 | cellular response to diacyl bacterial lipopeptide | 1.606201e-3 |
GO:0042496 | detection of diacyl bacterial lipopeptide | 1.606201e-3 |
GO:0060011 | Sertoli cell proliferation | 1.616104e-3 |
GO:0042982 | amyloid precursor protein metabolic process | 1.623819e-3 |
GO:0043039 | tRNA aminoacylation | 1.650059e-3 |
GO:0002315 | marginal zone B cell differentiation | 1.692964e-3 |
GO:0045064 | T-helper 2 cell differentiation | 1.692964e-3 |
GO:0043244 | regulation of protein complex disassembly | 1.693423e-3 |
GO:0051969 | regulation of transmission of nerve impulse | 1.717327e-3 |
GO:0007026 | negative regulation of microtubule depolymerization | 1.726326e-3 |
GO:0055098 | response to low-density lipoprotein particle stimulus | 1.729055e-3 |
GO:0048199 | vesicle targeting, to, from or within Golgi | 1.746866e-3 |
GO:0006397 | mRNA processing | 1.768940e-3 |
GO:0051656 | establishment of organelle localization | 1.817937e-3 |
GO:0033299 | secretion of lysosomal enzymes | 1.819448e-3 |
GO:0043388 | positive regulation of DNA binding | 1.826351e-3 |
GO:0032892 | positive regulation of organic acid transport | 1.832013e-3 |
GO:0043473 | pigmentation | 1.839681e-3 |
GO:0010469 | regulation of receptor activity | 1.840866e-3 |
GO:0043113 | receptor clustering | 1.877484e-3 |
GO:0032102 | negative regulation of response to external stimulus | 1.893715e-3 |
GO:0001523 | retinoid metabolic process | 1.903334e-3 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 1.956119e-3 |
GO:0045556 | positive regulation of TRAIL biosynthetic process | 1.993707e-3 |
GO:0001768 | establishment of T cell polarity | 2.003028e-3 |
GO:0060356 | leucine import | 2.020675e-3 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 2.020675e-3 |
GO:0035552 | oxidative single-stranded DNA demethylation | 2.020675e-3 |
GO:0006399 | tRNA metabolic process | 2.021538e-3 |
GO:0021561 | facial nerve development | 2.024956e-3 |
GO:0052200 | response to host defenses | 2.031708e-3 |
GO:0055094 | response to lipoprotein stimulus | 2.062310e-3 |
GO:0022411 | cellular component disassembly | 2.082879e-3 |
GO:0048167 | regulation of synaptic plasticity | 2.094454e-3 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 2.110535e-3 |
GO:0042245 | RNA repair | 2.115339e-3 |
GO:0030518 | steroid hormone receptor signaling pathway | 2.126965e-3 |
GO:0046850 | regulation of bone remodeling | 2.174581e-3 |
GO:0048205 | COPI coating of Golgi vesicle | 2.197559e-3 |
GO:0061198 | fungiform papilla formation | 2.202491e-3 |
GO:0006886 | intracellular protein transport | 2.267163e-3 |
GO:0048545 | response to steroid hormone stimulus | 2.272344e-3 |
GO:0000060 | protein import into nucleus, translocation | 2.340354e-3 |
GO:0002230 | positive regulation of defense response to virus by host | 2.397365e-3 |
GO:0010193 | response to ozone | 2.402089e-3 |
GO:0006776 | vitamin A metabolic process | 2.422015e-3 |
GO:0060005 | vestibular reflex | 2.437601e-3 |
GO:0070163 | regulation of adiponectin secretion | 2.466494e-3 |
GO:0021836 | chemorepulsion involved in postnatal olfactory bulb interneuron migration | 2.472177e-3 |
GO:0001503 | ossification | 2.489912e-3 |
GO:0048752 | semicircular canal morphogenesis | 2.492876e-3 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 2.507552e-3 |
GO:0008207 | C21-steroid hormone metabolic process | 2.549301e-3 |
GO:0007098 | centrosome cycle | 2.550239e-3 |
GO:0042481 | regulation of odontogenesis | 2.592808e-3 |
GO:0042921 | glucocorticoid receptor signaling pathway | 2.630126e-3 |
GO:0046883 | regulation of hormone secretion | 2.684626e-3 |
GO:0008380 | RNA splicing | 2.738097e-3 |
GO:0033198 | response to ATP | 2.758660e-3 |
GO:0051303 | establishment of chromosome localization | 2.797437e-3 |
GO:0032525 | somite rostral/caudal axis specification | 2.802493e-3 |
GO:0051222 | positive regulation of protein transport | 2.830465e-3 |
GO:0051580 | regulation of neurotransmitter uptake | 2.831402e-3 |
GO:0021870 | Cajal-Retzius cell differentiation | 2.873146e-3 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 2.919896e-3 |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 2.938896e-3 |
GO:0019730 | antimicrobial humoral response | 2.969343e-3 |
GO:0031114 | regulation of microtubule depolymerization | 2.990684e-3 |
GO:0021592 | fourth ventricle development | 2.995626e-3 |
GO:0010107 | potassium ion import | 3.039293e-3 |
GO:0010470 | regulation of gastrulation | 3.067549e-3 |
GO:0032663 | regulation of interleukin-2 production | 3.076793e-3 |
GO:0016101 | diterpenoid metabolic process | 3.107067e-3 |
GO:0001662 | behavioral fear response | 3.112364e-3 |
GO:0002718 | regulation of cytokine production involved in immune response | 3.127913e-3 |
GO:0032223 | negative regulation of synaptic transmission, cholinergic | 3.141485e-3 |
GO:0045212 | neurotransmitter receptor biosynthetic process | 3.141485e-3 |
GO:0006781 | succinyl-CoA pathway | 3.141485e-3 |
GO:0071223 | cellular response to lipoteichoic acid | 3.167759e-3 |
GO:0031110 | regulation of microtubule polymerization or depolymerization | 3.179796e-3 |
GO:0017148 | negative regulation of translation | 3.212899e-3 |
GO:0019439 | aromatic compound catabolic process | 3.223319e-3 |
GO:0042596 | fear response | 3.290960e-3 |
GO:0000183 | chromatin silencing at rDNA | 3.297501e-3 |
GO:0007220 | Notch receptor processing | 3.355180e-3 |
GO:0032707 | negative regulation of interleukin-23 production | 3.360084e-3 |
GO:0002051 | osteoblast fate commitment | 3.360084e-3 |
GO:0021546 | rhombomere development | 3.394365e-3 |
GO:0071221 | cellular response to bacterial lipopeptide | 3.394365e-3 |
GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis | 3.396838e-3 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 3.399123e-3 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 3.422617e-3 |
GO:0061180 | mammary gland epithelium development | 3.422625e-3 |
GO:0009266 | response to temperature stimulus | 3.444645e-3 |
GO:0033129 | positive regulation of histone phosphorylation | 3.451963e-3 |
GO:0048386 | positive regulation of retinoic acid receptor signaling pathway | 3.460009e-3 |
GO:0042404 | thyroid hormone catabolic process | 3.555717e-3 |
GO:0032355 | response to estradiol stimulus | 3.562754e-3 |
GO:0014050 | negative regulation of glutamate secretion | 3.605815e-3 |
GO:0003401 | axis elongation | 3.619348e-3 |
GO:0035039 | male pronucleus assembly | 3.701782e-3 |
GO:0061196 | fungiform papilla development | 3.750164e-3 |
GO:0006413 | translational initiation | 3.799961e-3 |
GO:0035094 | response to nicotine | 3.804619e-3 |
GO:0071312 | cellular response to alkaloid | 3.818457e-3 |
GO:0090022 | regulation of neutrophil chemotaxis | 3.931250e-3 |
GO:0060443 | mammary gland morphogenesis | 3.963570e-3 |
GO:0035921 | desmosome disassembly | 3.991064e-3 |
GO:0070563 | negative regulation of vitamin D receptor signaling pathway | 3.991064e-3 |
GO:0000086 | G2/M transition of mitotic cell cycle | 4.036578e-3 |
GO:0009235 | cobalamin metabolic process | 4.052516e-3 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 4.131281e-3 |
GO:0002209 | behavioral defense response | 4.170127e-3 |
GO:0006353 | transcription termination, DNA-dependent | 4.187723e-3 |
GO:0050796 | regulation of insulin secretion | 4.222505e-3 |
GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation | 4.249851e-3 |
GO:0016584 | nucleosome positioning | 4.252968e-3 |
GO:0043932 | ossification involved in bone remodeling | 4.252968e-3 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 4.268311e-3 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 4.283887e-3 |
GO:0034205 | beta-amyloid formation | 4.283887e-3 |
GO:0061046 | regulation of branching involved in lung morphogenesis | 4.341770e-3 |
GO:0032103 | positive regulation of response to external stimulus | 4.346908e-3 |
GO:0031111 | negative regulation of microtubule polymerization or depolymerization | 4.348095e-3 |
GO:0006396 | RNA processing | 4.358222e-3 |
GO:0045075 | regulation of interleukin-12 biosynthetic process | 4.384144e-3 |
GO:0032733 | positive regulation of interleukin-10 production | 4.392741e-3 |
GO:0032495 | response to muramyl dipeptide | 4.412436e-3 |
GO:0050995 | negative regulation of lipid catabolic process | 4.415192e-3 |
GO:0021678 | third ventricle development | 4.485317e-3 |
GO:0097039 | protein linear polyubiquitination | 4.485317e-3 |
GO:0006379 | mRNA cleavage | 4.566841e-3 |
GO:0016049 | cell growth | 4.628343e-3 |
GO:0043402 | glucocorticoid mediated signaling pathway | 4.661746e-3 |
GO:0048194 | Golgi vesicle budding | 4.721195e-3 |
GO:0003002 | regionalization | 4.736550e-3 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 4.759557e-3 |
GO:0016081 | synaptic vesicle docking involved in exocytosis | 4.823588e-3 |
GO:0043534 | blood vessel endothelial cell migration | 4.876886e-3 |
GO:0006414 | translational elongation | 4.882536e-3 |
GO:0070350 | regulation of white fat cell proliferation | 4.884347e-3 |
GO:0043526 | neuroprotection | 4.894652e-3 |
GO:0031117 | positive regulation of microtubule depolymerization | 4.930024e-3 |
GO:0000076 | DNA replication checkpoint | 4.938353e-3 |
GO:0045785 | positive regulation of cell adhesion | 5.034453e-3 |
GO:0009952 | anterior/posterior pattern specification | 5.080958e-3 |
GO:0007017 | microtubule-based process | 5.127105e-3 |
GO:0071822 | protein complex subunit organization | 5.143400e-3 |
GO:0033628 | regulation of cell adhesion mediated by integrin | 5.196291e-3 |
GO:0048871 | multicellular organismal homeostasis | 5.197183e-3 |
GO:0051043 | regulation of membrane protein ectodomain proteolysis | 5.245075e-3 |
GO:0032328 | alanine transport | 5.253608e-3 |
GO:0070507 | regulation of microtubule cytoskeleton organization | 5.282584e-3 |
GO:0006403 | RNA localization | 5.287984e-3 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 5.313032e-3 |
GO:0031064 | negative regulation of histone deacetylation | 5.331048e-3 |
GO:0051101 | regulation of DNA binding | 5.332670e-3 |
GO:0045415 | negative regulation of interleukin-8 biosynthetic process | 5.355509e-3 |
GO:0033158 | regulation of protein import into nucleus, translocation | 5.355869e-3 |
GO:0043200 | response to amino acid stimulus | 5.359645e-3 |
GO:0071845 | cellular component disassembly at cellular level | 5.371515e-3 |
GO:0021570 | rhombomere 4 development | 5.388726e-3 |
GO:0060611 | mammary gland fat development | 5.450039e-3 |
GO:0071436 | sodium ion export | 5.461354e-3 |
GO:0043401 | steroid hormone mediated signaling pathway | 5.565988e-3 |
GO:0061011 | hepatic duct development | 5.631163e-3 |
GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin | 5.638183e-3 |
GO:0009651 | response to salt stress | 5.703980e-3 |
GO:0002699 | positive regulation of immune effector process | 5.929445e-3 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 5.938494e-3 |
GO:0006892 | post-Golgi vesicle-mediated transport | 6.007517e-3 |
GO:0006590 | thyroid hormone generation | 6.048072e-3 |
GO:0016080 | synaptic vesicle targeting | 6.131457e-3 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 6.208417e-3 |
GO:0000132 | establishment of mitotic spindle orientation | 6.221321e-3 |
GO:0043060 | meiotic metaphase I plate congression | 6.224642e-3 |
GO:0090009 | primitive streak formation | 6.366435e-3 |
GO:0030917 | midbrain-hindbrain boundary development | 6.408342e-3 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 6.454468e-3 |
GO:0032967 | positive regulation of collagen biosynthetic process | 6.594482e-3 |
GO:0045630 | positive regulation of T-helper 2 cell differentiation | 6.621238e-3 |
GO:0051594 | detection of glucose | 6.691015e-3 |
GO:0014070 | response to organic cyclic compound | 6.699173e-3 |
GO:0051255 | spindle midzone assembly | 6.700592e-3 |
GO:0006446 | regulation of translational initiation | 6.706649e-3 |
GO:0015698 | inorganic anion transport | 6.721362e-3 |
GO:0030224 | monocyte differentiation | 6.726994e-3 |
GO:0010572 | positive regulation of platelet activation | 6.849260e-3 |
GO:2000348 | regulation of CD40 signaling pathway | 6.934737e-3 |
GO:0046827 | positive regulation of protein export from nucleus | 6.939462e-3 |
GO:0044060 | regulation of endocrine process | 6.953752e-3 |
GO:0032770 | positive regulation of monooxygenase activity | 7.008641e-3 |
GO:0043380 | regulation of memory T cell differentiation | 7.026452e-3 |
GO:0060602 | branch elongation of an epithelium | 7.041239e-3 |
GO:0021993 | initiation of neural tube closure | 7.098577e-3 |
GO:0032653 | regulation of interleukin-10 production | 7.185568e-3 |
GO:0042733 | embryonic digit morphogenesis | 7.289647e-3 |
GO:0046849 | bone remodeling | 7.351618e-3 |
GO:0051971 | positive regulation of transmission of nerve impulse | 7.368008e-3 |
GO:0045076 | regulation of interleukin-2 biosynthetic process | 7.428723e-3 |
GO:0042403 | thyroid hormone metabolic process | 7.444163e-3 |
GO:0051412 | response to corticosterone stimulus | 7.496585e-3 |
GO:0042219 | cellular modified amino acid catabolic process | 7.574584e-3 |
GO:0032474 | otolith morphogenesis | 7.591613e-3 |
GO:0050720 | interleukin-1 beta biosynthetic process | 7.591613e-3 |
GO:0042407 | cristae formation | 7.591613e-3 |
GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 7.591613e-3 |
GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 7.591613e-3 |
GO:2000330 | positive regulation of T-helper 17 cell lineage commitment | 7.621648e-3 |
GO:2000318 | positive regulation of T-helper 17 type immune response | 7.621648e-3 |
GO:0043585 | nose morphogenesis | 7.666939e-3 |
GO:0006927 | transformed cell apoptosis | 7.666939e-3 |
GO:0010468 | regulation of gene expression | 7.673572e-3 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 7.800708e-3 |
GO:0006605 | protein targeting | 7.915016e-3 |
GO:0044403 | symbiosis, encompassing mutualism through parasitism | 7.924007e-3 |
GO:0006405 | RNA export from nucleus | 7.967142e-3 |
GO:0045663 | positive regulation of myoblast differentiation | 8.002235e-3 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 8.044633e-3 |
GO:0000578 | embryonic axis specification | 8.064498e-3 |
GO:0045885 | positive regulation of survival gene product expression | 8.087653e-3 |
GO:0040001 | establishment of mitotic spindle localization | 8.139363e-3 |
GO:0006979 | response to oxidative stress | 8.166877e-3 |
GO:0010225 | response to UV-C | 8.176216e-3 |
GO:0010626 | negative regulation of Schwann cell proliferation | 8.328023e-3 |
GO:0051643 | endoplasmic reticulum localization | 8.390361e-3 |
GO:0051588 | regulation of neurotransmitter transport | 8.462695e-3 |
GO:0043112 | receptor metabolic process | 8.464616e-3 |
GO:0009635 | response to herbicide | 8.491088e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0070646 | protein modification by small protein removal | 1.612368e-50 |
GO:0016579 | protein deubiquitination | 4.002496e-50 |
GO:0070647 | protein modification by small protein conjugation or removal | 1.123604e-14 |
GO:0032849 | positive regulation of cellular pH reduction | 4.404023e-10 |
GO:0006508 | proteolysis | 4.574692e-9 |
GO:0048026 | positive regulation of nuclear mRNA splicing, via spliceosome | 3.059442e-8 |
GO:0048247 | lymphocyte chemotaxis | 3.309936e-8 |
GO:0042119 | neutrophil activation | 3.382526e-8 |
GO:0046784 | intronless viral mRNA export from host nucleus | 1.398778e-7 |
GO:0002344 | B cell affinity maturation | 1.527822e-7 |
GO:0048240 | sperm capacitation | 1.539645e-7 |
GO:0015670 | carbon dioxide transport | 2.324900e-7 |
GO:0002827 | positive regulation of T-helper 1 type immune response | 2.450558e-7 |
GO:0002446 | neutrophil mediated immunity | 3.065837e-7 |
GO:0015669 | gas transport | 3.163730e-7 |
GO:0032847 | regulation of cellular pH reduction | 4.186879e-7 |
GO:0009134 | nucleoside diphosphate catabolic process | 5.345666e-7 |
GO:0008616 | queuosine biosynthetic process | 9.098222e-7 |
GO:0044260 | cellular macromolecule metabolic process | 1.029084e-6 |
GO:0016078 | tRNA catabolic process | 1.540253e-6 |
GO:0001682 | tRNA 5'-leader removal | 1.540253e-6 |
GO:2000345 | regulation of hepatocyte proliferation | 1.737983e-6 |
GO:0060012 | synaptic transmission, glycinergic | 2.302310e-6 |
GO:0051659 | maintenance of mitochondrion location | 2.418800e-6 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 2.703597e-6 |
GO:0031448 | positive regulation of fast-twitch skeletal muscle fiber contraction | 3.177413e-6 |
GO:0045104 | intermediate filament cytoskeleton organization | 3.814902e-6 |
GO:0034587 | piRNA metabolic process | 3.966944e-6 |
GO:0003350 | pulmonary myocardium development | 4.270089e-6 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 4.890802e-6 |
GO:0008152 | metabolic process | 5.068305e-6 |
GO:0032074 | negative regulation of nuclease activity | 5.202427e-6 |
GO:0042026 | protein refolding | 5.458059e-6 |
GO:0002339 | B cell selection | 7.356706e-6 |
GO:0090086 | negative regulation of protein deubiquitination | 7.543508e-6 |
GO:0072573 | tolerance induction to lipopolysaccharide | 7.583143e-6 |
GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 7.583143e-6 |
GO:2000349 | negative regulation of CD40 signaling pathway | 7.583143e-6 |
GO:0070429 | negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 7.583143e-6 |
GO:0002632 | negative regulation of granuloma formation | 7.583143e-6 |
GO:0034148 | negative regulation of toll-like receptor 5 signaling pathway | 7.583143e-6 |
GO:0016559 | peroxisome fission | 8.638308e-6 |
GO:0045103 | intermediate filament-based process | 8.731744e-6 |
GO:0072676 | lymphocyte migration | 9.356139e-6 |
GO:0070389 | chaperone cofactor-dependent protein refolding | 9.967730e-6 |
GO:0055015 | ventricular cardiac muscle cell development | 1.114842e-5 |
GO:0045780 | positive regulation of bone resorption | 1.135771e-5 |
GO:0043170 | macromolecule metabolic process | 1.252414e-5 |
GO:0051321 | meiotic cell cycle | 1.302494e-5 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 1.337087e-5 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB cascade | 1.570099e-5 |
GO:0002443 | leukocyte mediated immunity | 1.601211e-5 |
GO:0051657 | maintenance of organelle location | 1.727716e-5 |
GO:2000347 | positive regulation of hepatocyte proliferation | 1.768219e-5 |
GO:0006290 | pyrimidine dimer repair | 1.779821e-5 |
GO:0046850 | regulation of bone remodeling | 1.786112e-5 |
GO:0033120 | positive regulation of RNA splicing | 1.826417e-5 |
GO:0045124 | regulation of bone resorption | 2.045587e-5 |
GO:0002444 | myeloid leukocyte mediated immunity | 2.417822e-5 |
GO:0060052 | neurofilament cytoskeleton organization | 2.444326e-5 |
GO:0061077 | chaperone-mediated protein folding | 2.485995e-5 |
GO:0031444 | slow-twitch skeletal muscle fiber contraction | 2.634636e-5 |
GO:0034105 | positive regulation of tissue remodeling | 2.703039e-5 |
GO:0048536 | spleen development | 2.920434e-5 |
GO:0070432 | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 2.987399e-5 |
GO:0090076 | relaxation of skeletal muscle | 2.987399e-5 |
GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 2.987399e-5 |
GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway | 2.987399e-5 |
GO:0032470 | elevation of endoplasmic reticulum calcium ion concentration | 2.987399e-5 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 3.034507e-5 |
GO:0034115 | negative regulation of heterotypic cell-cell adhesion | 3.210741e-5 |
GO:0031133 | regulation of axon diameter | 3.210741e-5 |
GO:0002315 | marginal zone B cell differentiation | 3.537850e-5 |
GO:0016578 | histone deubiquitination | 3.875880e-5 |
GO:0060600 | dichotomous subdivision of an epithelial terminal unit | 3.891032e-5 |
GO:0071824 | protein-DNA complex subunit organization | 4.179236e-5 |
GO:0051561 | elevation of mitochondrial calcium ion concentration | 4.741492e-5 |
GO:0051313 | attachment of spindle microtubules to chromosome | 4.903100e-5 |
GO:0044238 | primary metabolic process | 5.397178e-5 |
GO:0002829 | negative regulation of type 2 immune response | 5.613355e-5 |
GO:0002693 | positive regulation of cellular extravasation | 5.683638e-5 |
GO:0006334 | nucleosome assembly | 6.247634e-5 |
GO:0008617 | guanosine metabolic process | 6.416932e-5 |
GO:0060841 | venous blood vessel development | 7.046695e-5 |
GO:0002825 | regulation of T-helper 1 type immune response | 7.481208e-5 |
GO:2000348 | regulation of CD40 signaling pathway | 7.835154e-5 |
GO:0044237 | cellular metabolic process | 9.721146e-5 |
GO:0002407 | dendritic cell chemotaxis | 1.016474e-4 |
GO:0070509 | calcium ion import | 1.019011e-4 |
GO:2000507 | positive regulation of energy homeostasis | 1.025509e-4 |
GO:2000253 | positive regulation of feeding behavior | 1.025509e-4 |
GO:0042637 | catagen | 1.025509e-4 |
GO:0070536 | protein K63-linked deubiquitination | 1.038630e-4 |
GO:0032536 | regulation of cell projection size | 1.145459e-4 |
GO:0065004 | protein-DNA complex assembly | 1.186336e-4 |
GO:0030854 | positive regulation of granulocyte differentiation | 1.203635e-4 |
GO:0006457 | protein folding | 1.252065e-4 |
GO:0006970 | response to osmotic stress | 1.473874e-4 |
GO:0007126 | meiosis | 1.548380e-4 |
GO:0001906 | cell killing | 1.555595e-4 |
GO:0035752 | lysosomal lumen pH elevation | 1.574583e-4 |
GO:0001575 | globoside metabolic process | 1.574583e-4 |
GO:0000046 | autophagic vacuole fusion | 1.574583e-4 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 1.614954e-4 |
GO:0032846 | positive regulation of homeostatic process | 1.652163e-4 |
GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway | 1.724061e-4 |
GO:0045109 | intermediate filament organization | 1.742102e-4 |
GO:0010507 | negative regulation of autophagy | 1.745510e-4 |
GO:2000344 | positive regulation of acrosome reaction | 1.774495e-4 |
GO:0034728 | nucleosome organization | 1.781804e-4 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 1.825203e-4 |
GO:0002579 | positive regulation of antigen processing and presentation | 1.852929e-4 |
GO:0032663 | regulation of interleukin-2 production | 1.875642e-4 |
GO:0006259 | DNA metabolic process | 1.941576e-4 |
GO:0010631 | epithelial cell migration | 2.059853e-4 |
GO:0060592 | mammary gland formation | 2.235369e-4 |
GO:0001922 | B-1 B cell homeostasis | 2.248780e-4 |
GO:0071243 | cellular response to arsenic-containing substance | 2.299909e-4 |
GO:0031034 | myosin filament assembly | 2.427374e-4 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 2.496130e-4 |
GO:0048384 | retinoic acid receptor signaling pathway | 2.738587e-4 |
GO:0003012 | muscle system process | 2.755293e-4 |
GO:0002763 | positive regulation of myeloid leukocyte differentiation | 2.836987e-4 |
GO:0034139 | regulation of toll-like receptor 3 signaling pathway | 2.868526e-4 |
GO:0002761 | regulation of myeloid leukocyte differentiation | 2.913948e-4 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 2.975757e-4 |
GO:0002274 | myeloid leukocyte activation | 3.004542e-4 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 3.060432e-4 |
GO:0009132 | nucleoside diphosphate metabolic process | 3.207191e-4 |
GO:0043353 | enucleate erythrocyte differentiation | 3.218614e-4 |
GO:0030183 | B cell differentiation | 3.267794e-4 |
GO:0070537 | histone H2A K63-linked deubiquitination | 3.286873e-4 |
GO:0033299 | secretion of lysosomal enzymes | 3.286873e-4 |
GO:0051701 | interaction with host | 3.317776e-4 |
GO:0055005 | ventricular cardiac myofibril development | 4.101520e-4 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 4.219726e-4 |
GO:0021516 | dorsal spinal cord development | 4.348108e-4 |
GO:0010724 | regulation of definitive erythrocyte differentiation | 4.355880e-4 |
GO:0030718 | germ-line stem cell maintenance | 4.453849e-4 |
GO:0034103 | regulation of tissue remodeling | 4.814459e-4 |
GO:0070561 | vitamin D receptor signaling pathway | 4.858024e-4 |
GO:0048284 | organelle fusion | 5.010445e-4 |
GO:0070098 | chemokine-mediated signaling pathway | 5.504242e-4 |
GO:0055003 | cardiac myofibril assembly | 5.635241e-4 |
GO:0040016 | embryonic cleavage | 5.680637e-4 |
GO:0048660 | regulation of smooth muscle cell proliferation | 5.723228e-4 |
GO:0032204 | regulation of telomere maintenance | 5.825344e-4 |
GO:0014819 | regulation of skeletal muscle contraction | 5.924925e-4 |
GO:0090085 | regulation of protein deubiquitination | 5.939331e-4 |
GO:0090084 | negative regulation of inclusion body assembly | 5.939331e-4 |
GO:0002335 | mature B cell differentiation | 6.023326e-4 |
GO:0006780 | uroporphyrinogen III biosynthetic process | 6.063724e-4 |
GO:0046079 | dUMP catabolic process | 6.097049e-4 |
GO:0043310 | negative regulation of eosinophil degranulation | 6.097049e-4 |
GO:2000409 | positive regulation of T cell extravasation | 6.097049e-4 |
GO:0070535 | histone H2A K63-linked ubiquitination | 6.097049e-4 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 6.097049e-4 |
GO:0035696 | monocyte extravasation | 6.097049e-4 |
GO:0035705 | T-helper 17 cell chemotaxis | 6.097049e-4 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 6.666009e-4 |
GO:0031032 | actomyosin structure organization | 6.770705e-4 |
GO:0007141 | male meiosis I | 6.855094e-4 |
GO:0045931 | positive regulation of mitotic cell cycle | 6.935951e-4 |
GO:0014048 | regulation of glutamate secretion | 7.288002e-4 |
GO:0061113 | pancreas morphogenesis | 7.394296e-4 |
GO:0009987 | cellular process | 7.407779e-4 |
GO:0002313 | mature B cell differentiation involved in immune response | 7.679534e-4 |
GO:0043201 | response to leucine | 7.783935e-4 |
GO:0060730 | regulation of intestinal epithelial structure maintenance | 7.835972e-4 |
GO:0035883 | enteroendocrine cell differentiation | 7.835972e-4 |
GO:0010984 | regulation of lipoprotein particle clearance | 7.840631e-4 |
GO:0060788 | ectodermal placode formation | 7.996900e-4 |
GO:0023035 | CD40 signaling pathway | 7.997383e-4 |
GO:0055013 | cardiac muscle cell development | 7.998894e-4 |
GO:0006396 | RNA processing | 8.037591e-4 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB cascade | 8.260939e-4 |
GO:0006972 | hyperosmotic response | 8.295850e-4 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 8.385988e-4 |
GO:0006936 | muscle contraction | 8.572512e-4 |
GO:0007140 | male meiosis | 8.824943e-4 |
GO:0061004 | pattern specification involved in kidney development | 9.119842e-4 |
GO:0051276 | chromosome organization | 9.244612e-4 |
GO:0030218 | erythrocyte differentiation | 9.639243e-4 |
GO:0002087 | regulation of respiratory gaseous exchange by neurological system process | 9.713805e-4 |
GO:0006600 | creatine metabolic process | 9.804068e-4 |
GO:0003329 | pancreatic PP cell fate commitment | 9.926612e-4 |
GO:0071474 | cellular hyperosmotic response | 9.926612e-4 |
GO:0003326 | pancreatic A cell fate commitment | 9.926612e-4 |
GO:0019048 | virus-host interaction | 1.011982e-3 |
GO:0000381 | regulation of alternative nuclear mRNA splicing, via spliceosome | 1.027162e-3 |
GO:0034101 | erythrocyte homeostasis | 1.039903e-3 |
GO:0030852 | regulation of granulocyte differentiation | 1.044714e-3 |
GO:0044403 | symbiosis, encompassing mutualism through parasitism | 1.062600e-3 |
GO:0055014 | atrial cardiac muscle cell development | 1.075514e-3 |
GO:0032509 | endosome transport via multivesicular body sorting pathway | 1.077627e-3 |
GO:0060696 | regulation of phospholipid catabolic process | 1.172346e-3 |
GO:0019441 | tryptophan catabolic process to kynurenine | 1.172346e-3 |
GO:0009651 | response to salt stress | 1.182342e-3 |
GO:0034453 | microtubule anchoring | 1.189936e-3 |
GO:0032703 | negative regulation of interleukin-2 production | 1.189936e-3 |
GO:0051454 | intracellular pH elevation | 1.208878e-3 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 1.225926e-3 |
GO:0070587 | regulation of cell-cell adhesion involved in gastrulation | 1.225926e-3 |
GO:0034114 | regulation of heterotypic cell-cell adhesion | 1.225926e-3 |
GO:0035966 | response to topologically incorrect protein | 1.232096e-3 |
GO:0035849 | nephric duct elongation | 1.241469e-3 |
GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation | 1.241469e-3 |
GO:0035852 | horizontal cell localization | 1.241469e-3 |
GO:0035846 | oviduct epithelium development | 1.241469e-3 |
GO:0035847 | uterine epithelium development | 1.241469e-3 |
GO:0051791 | medium-chain fatty acid metabolic process | 1.243225e-3 |
GO:0051315 | attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation | 1.243225e-3 |
GO:0019751 | polyol metabolic process | 1.247470e-3 |
GO:0030239 | myofibril assembly | 1.267762e-3 |
GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway | 1.335244e-3 |
GO:0002125 | maternal aggressive behavior | 1.350264e-3 |
GO:0044065 | regulation of respiratory system process | 1.354442e-3 |
GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway | 1.395067e-3 |
GO:0046668 | regulation of retinal cell programmed cell death | 1.395067e-3 |
GO:0009992 | cellular water homeostasis | 1.413759e-3 |
GO:0055006 | cardiac cell development | 1.464528e-3 |
GO:0045989 | positive regulation of striated muscle contraction | 1.512299e-3 |
GO:0060445 | branching involved in salivary gland morphogenesis | 1.542859e-3 |
GO:0051584 | regulation of dopamine uptake | 1.591558e-3 |
GO:0031573 | intra-S DNA damage checkpoint | 1.591558e-3 |
GO:0006944 | cellular membrane fusion | 1.597346e-3 |
GO:0002577 | regulation of antigen processing and presentation | 1.600934e-3 |
GO:0035767 | endothelial cell chemotaxis | 1.652337e-3 |
GO:0044091 | membrane biogenesis | 1.668789e-3 |
GO:0035372 | protein localization to microtubule | 1.668789e-3 |
GO:0000027 | ribosomal large subunit assembly | 1.672495e-3 |
GO:0009159 | deoxyribonucleoside monophosphate catabolic process | 1.672495e-3 |
GO:0032469 | endoplasmic reticulum calcium ion homeostasis | 1.717833e-3 |
GO:0051788 | response to misfolded protein | 1.722886e-3 |
GO:0034621 | cellular macromolecular complex subunit organization | 1.725473e-3 |
GO:0035881 | amacrine cell differentiation | 1.795514e-3 |
GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion | 1.795514e-3 |
GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep | 1.811233e-3 |
GO:0051883 | killing of cells in other organism involved in symbiotic interaction | 1.881765e-3 |
GO:0010957 | negative regulation of vitamin D biosynthetic process | 1.965015e-3 |
GO:0060745 | mammary gland branching involved in pregnancy | 1.983575e-3 |
GO:0006333 | chromatin assembly or disassembly | 2.011091e-3 |
GO:0031640 | killing of cells of other organism | 2.099990e-3 |
GO:0060389 | pathway-restricted SMAD protein phosphorylation | 2.099990e-3 |
GO:0042107 | cytokine metabolic process | 2.128788e-3 |
GO:0043056 | forward locomotion | 2.153489e-3 |
GO:0043576 | regulation of respiratory gaseous exchange | 2.158674e-3 |
GO:0015802 | basic amino acid transport | 2.263799e-3 |
GO:0019538 | protein metabolic process | 2.304711e-3 |
GO:0006916 | anti-apoptosis | 2.305353e-3 |
GO:0044267 | cellular protein metabolic process | 2.427602e-3 |
GO:0050850 | positive regulation of calcium-mediated signaling | 2.436347e-3 |
GO:0061025 | membrane fusion | 2.464617e-3 |
GO:0002518 | lymphocyte chemotaxis across high endothelial venule | 2.564221e-3 |
GO:0048631 | regulation of skeletal muscle tissue growth | 2.580927e-3 |
GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport | 2.580927e-3 |
GO:0002432 | granuloma formation | 2.580927e-3 |
GO:0016557 | peroxisome membrane biogenesis | 2.580927e-3 |
GO:0048738 | cardiac muscle tissue development | 2.634589e-3 |
GO:0060527 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis | 2.817497e-3 |
GO:0030099 | myeloid cell differentiation | 2.824870e-3 |
GO:0090083 | regulation of inclusion body assembly | 2.833251e-3 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 2.837206e-3 |
GO:0060596 | mammary placode formation | 2.861362e-3 |
GO:0006139 | nucleobase-containing compound metabolic process | 2.892326e-3 |
GO:0060298 | positive regulation of sarcomere organization | 2.981968e-3 |
GO:0046685 | response to arsenic-containing substance | 3.206790e-3 |
GO:0003278 | apoptosis involved in heart morphogenesis | 3.257379e-3 |
GO:0006105 | succinate metabolic process | 3.275948e-3 |
GO:0046619 | optic placode formation involved in camera-type eye formation | 3.317912e-3 |
GO:0010458 | exit from mitosis | 3.390359e-3 |
GO:0019835 | cytolysis | 3.400494e-3 |
GO:0050848 | regulation of calcium-mediated signaling | 3.441276e-3 |
GO:0035235 | ionotropic glutamate receptor signaling pathway | 3.490294e-3 |
GO:0035768 | endothelial cell chemotaxis to fibroblast growth factor | 3.569670e-3 |
GO:0035754 | B cell chemotaxis | 3.569670e-3 |
GO:0002449 | lymphocyte mediated immunity | 3.594853e-3 |
GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway | 3.605505e-3 |
GO:0042113 | B cell activation | 3.695526e-3 |
GO:0003285 | septum secundum development | 3.736587e-3 |
GO:0006397 | mRNA processing | 3.871737e-3 |
GO:2000505 | regulation of energy homeostasis | 3.937445e-3 |
GO:0033239 | negative regulation of cellular amine metabolic process | 3.937445e-3 |
GO:0050869 | negative regulation of B cell activation | 3.947952e-3 |
GO:0019400 | alditol metabolic process | 3.966401e-3 |
GO:0045672 | positive regulation of osteoclast differentiation | 3.999932e-3 |
GO:0008380 | RNA splicing | 4.039047e-3 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 4.054211e-3 |
GO:0007040 | lysosome organization | 4.073759e-3 |
GO:0019530 | taurine metabolic process | 4.168401e-3 |
GO:0034605 | cellular response to heat | 4.218867e-3 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 4.235257e-3 |
GO:0090304 | nucleic acid metabolic process | 4.288642e-3 |
GO:0042089 | cytokine biosynthetic process | 4.288833e-3 |
GO:0033058 | directional locomotion | 4.323721e-3 |
GO:0051792 | medium-chain fatty acid biosynthetic process | 4.565648e-3 |
GO:0021703 | locus ceruleus development | 4.565648e-3 |
GO:0035502 | metanephric ureteric bud development | 4.565648e-3 |
GO:0032463 | negative regulation of protein homooligomerization | 4.613736e-3 |
GO:0051568 | histone H3-K4 methylation | 4.657224e-3 |
GO:2000744 | positive regulation of anterior head development | 4.668428e-3 |
GO:0042094 | interleukin-2 biosynthetic process | 4.668428e-3 |
GO:0055012 | ventricular cardiac muscle cell differentiation | 4.716968e-3 |
GO:0007031 | peroxisome organization | 4.761070e-3 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 4.767414e-3 |
GO:0007215 | glutamate signaling pathway | 4.787586e-3 |
GO:0061205 | paramesonephric duct development | 4.821586e-3 |
GO:0051146 | striated muscle cell differentiation | 4.855661e-3 |
GO:0090174 | organelle membrane fusion | 4.911927e-3 |
GO:2001052 | positive regulation of G1/S transition checkpoint | 4.911927e-3 |
GO:0032915 | positive regulation of transforming growth factor beta2 production | 4.911927e-3 |
GO:0072574 | hepatocyte proliferation | 4.911927e-3 |
GO:0002194 | hepatocyte cell migration | 4.911927e-3 |
GO:0031497 | chromatin assembly | 4.944345e-3 |
GO:0044319 | wound healing, spreading of cells | 5.085100e-3 |
GO:0045047 | protein targeting to ER | 5.256484e-3 |
GO:0070669 | response to interleukin-2 | 5.338843e-3 |
GO:0048143 | astrocyte activation | 5.693890e-3 |
GO:0042742 | defense response to bacterium | 5.752744e-3 |
GO:0032623 | interleukin-2 production | 5.770784e-3 |
GO:0060075 | regulation of resting membrane potential | 5.770784e-3 |
GO:0051580 | regulation of neurotransmitter uptake | 5.822632e-3 |
GO:0032652 | regulation of interleukin-1 production | 6.182739e-3 |
GO:0006289 | nucleotide-excision repair | 6.195806e-3 |
GO:0016192 | vesicle-mediated transport | 6.196004e-3 |
GO:0048680 | positive regulation of axon regeneration | 6.247252e-3 |
GO:0019853 | L-ascorbic acid biosynthetic process | 6.289465e-3 |
GO:0006568 | tryptophan metabolic process | 6.289465e-3 |
GO:0016071 | mRNA metabolic process | 6.513416e-3 |
GO:0060928 | atrioventricular node cell development | 6.532968e-3 |
GO:0060929 | atrioventricular node cell fate commitment | 6.532968e-3 |
GO:0015739 | sialic acid transport | 6.532968e-3 |
GO:0003342 | proepicardium development | 6.532968e-3 |
GO:0003168 | cardiac Purkinje fiber cell differentiation | 6.532968e-3 |
GO:0000715 | nucleotide-excision repair, DNA damage recognition | 6.544406e-3 |
GO:0060013 | righting reflex | 6.569768e-3 |
GO:0051574 | positive regulation of histone H3-K9 methylation | 6.569768e-3 |
GO:0007220 | Notch receptor processing | 6.604318e-3 |
GO:0001743 | optic placode formation | 6.652205e-3 |
GO:0006406 | mRNA export from nucleus | 6.852966e-3 |
GO:0045351 | type I interferon biosynthetic process | 6.962896e-3 |
GO:0042984 | regulation of amyloid precursor protein biosynthetic process | 6.962896e-3 |
GO:0019439 | aromatic compound catabolic process | 7.040622e-3 |
GO:0031330 | negative regulation of cellular catabolic process | 7.153607e-3 |
GO:0070189 | kynurenine metabolic process | 7.163623e-3 |
GO:0032769 | negative regulation of monooxygenase activity | 7.163623e-3 |
GO:0060347 | heart trabecula formation | 7.164235e-3 |
GO:0032651 | regulation of interleukin-1 beta production | 7.168104e-3 |
GO:0001779 | natural killer cell differentiation | 7.174078e-3 |
GO:0007258 | JUN phosphorylation | 7.221633e-3 |
GO:0072081 | specification of nephron tubule identity | 7.221633e-3 |
GO:0032692 | negative regulation of interleukin-1 production | 7.228642e-3 |
GO:0035051 | cardiac cell differentiation | 7.481150e-3 |
GO:0048872 | homeostasis of number of cells | 7.629594e-3 |
GO:0010040 | response to iron(II) ion | 7.737725e-3 |
GO:0060396 | growth hormone receptor signaling pathway | 7.787344e-3 |
GO:0048002 | antigen processing and presentation of peptide antigen | 7.855785e-3 |
GO:2000741 | positive regulation of mesenchymal stem cell differentiation | 7.915801e-3 |
GO:0048251 | elastic fiber assembly | 7.915801e-3 |
GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep | 7.915801e-3 |
GO:0002507 | tolerance induction | 7.944400e-3 |
GO:0043412 | macromolecule modification | 8.074814e-3 |
GO:0014706 | striated muscle tissue development | 8.074974e-3 |
GO:0048009 | insulin-like growth factor receptor signaling pathway | 8.106625e-3 |
GO:0016926 | protein desumoylation | 8.199586e-3 |
GO:0006566 | threonine metabolic process | 8.199586e-3 |
GO:0006278 | RNA-dependent DNA replication | 8.217118e-3 |
GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin | 8.279989e-3 |
GO:0045650 | negative regulation of macrophage differentiation | 8.279989e-3 |
GO:0015860 | purine nucleoside transport | 8.279989e-3 |
GO:0043457 | regulation of cellular respiration | 8.370228e-3 |
GO:0070541 | response to platinum ion | 8.421688e-3 |
GO:0051593 | response to folic acid | 8.517226e-3 |
GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 8.542203e-3 |
GO:0070858 | negative regulation of bile acid biosynthetic process | 8.547890e-3 |
GO:0046341 | CDP-diacylglycerol metabolic process | 8.547890e-3 |
GO:0006464 | protein modification process | 8.760884e-3 |
GO:0007023 | post-chaperonin tubulin folding pathway | 8.781290e-3 |
GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion | 8.781290e-3 |
GO:0019836 | hemolysis by symbiont of host erythrocytes | 8.824130e-3 |
GO:0051622 | negative regulation of norepinephrine uptake | 9.105163e-3 |
GO:0051585 | negative regulation of dopamine uptake | 9.105163e-3 |
GO:0070495 | negative regulation of thrombin receptor signaling pathway | 9.105163e-3 |
GO:0033490 | cholesterol biosynthetic process via lathosterol | 9.105163e-3 |
GO:0050812 | regulation of acyl-CoA biosynthetic process | 9.105163e-3 |
GO:0051382 | kinetochore assembly | 9.105163e-3 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 9.163043e-3 |
GO:0014866 | skeletal myofibril assembly | 9.268968e-3 |
GO:0045988 | negative regulation of striated muscle contraction | 9.354576e-3 |
GO:0071378 | cellular response to growth hormone stimulus | 9.354576e-3 |
GO:0046709 | IDP catabolic process | 9.579107e-3 |
GO:0046032 | ADP catabolic process | 9.579107e-3 |
GO:0060215 | primitive hemopoiesis | 9.747905e-3 |
GO:0043001 | Golgi to plasma membrane protein transport | 9.747905e-3 |
GO:0046449 | creatinine metabolic process | 9.782138e-3 |
GO:0090096 | positive regulation of metanephric cap mesenchymal cell proliferation | 1.000568e-2 |
GO:0035162 | embryonic hemopoiesis | 1.009404e-2 |
GO:0055002 | striated muscle cell development | 1.028016e-2 |
GO:0043550 | regulation of lipid kinase activity | 1.031478e-2 |
GO:0050685 | positive regulation of mRNA processing | 1.042134e-2 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1.047631e-2 |
GO:0046670 | positive regulation of retinal cell programmed cell death | 1.049956e-2 |
GO:0008626 | induction of apoptosis by granzyme | 1.049956e-2 |
GO:0000966 | RNA 5'-end processing | 1.049956e-2 |
GO:0002525 | acute inflammatory response to non-antigenic stimulus | 1.049956e-2 |
GO:0060537 | muscle tissue development | 1.057856e-2 |
GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 1.058309e-2 |
GO:0002312 | B cell activation involved in immune response | 1.059174e-2 |
GO:0035313 | wound healing, spreading of epidermal cells | 1.075312e-2 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 1.076476e-2 |
GO:0071594 | thymocyte aggregation | 1.076476e-2 |
GO:0046967 | cytosol to ER transport | 1.076476e-2 |
GO:0033979 | box H/ACA snoRNA metabolic process | 1.076476e-2 |
GO:0019060 | intracellular transport of viral proteins in host cell | 1.076476e-2 |
GO:0006284 | base-excision repair | 1.077581e-2 |
GO:0006612 | protein targeting to membrane | 1.079170e-2 |
GO:0072086 | specification of loop of Henle identity | 1.089977e-2 |
GO:0006071 | glycerol metabolic process | 1.090540e-2 |
GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway | 1.096725e-2 |
GO:0006996 | organelle organization | 1.114522e-2 |
GO:0007286 | spermatid development | 1.127711e-2 |
GO:0060174 | limb bud formation | 1.140236e-2 |
GO:0051545 | negative regulation of elastin biosynthetic process | 1.155194e-2 |
GO:0090321 | positive regulation of chylomicron remnant clearance | 1.155194e-2 |
GO:2000002 | negative regulation of DNA damage checkpoint | 1.155194e-2 |
GO:0022004 | midbrain-hindbrain boundary maturation during brain development | 1.155194e-2 |
GO:0090319 | positive regulation of chylomicron remodeling | 1.155194e-2 |
GO:0006709 | progesterone catabolic process | 1.155194e-2 |
GO:0009249 | protein lipoylation | 1.155194e-2 |
GO:0021551 | central nervous system morphogenesis | 1.155194e-2 |
GO:0021588 | cerebellum formation | 1.155194e-2 |
GO:0046834 | lipid phosphorylation | 1.175326e-2 |
GO:0072194 | kidney smooth muscle tissue development | 1.185591e-2 |
GO:0010820 | positive regulation of T cell chemotaxis | 1.190579e-2 |
GO:0034622 | cellular macromolecular complex assembly | 1.201262e-2 |
GO:0022408 | negative regulation of cell-cell adhesion | 1.204131e-2 |
GO:0070346 | positive regulation of fat cell proliferation | 1.209538e-2 |
GO:0048672 | positive regulation of collateral sprouting | 1.209538e-2 |
GO:0051612 | negative regulation of serotonin uptake | 1.209538e-2 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.211635e-2 |
GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 1.211635e-2 |
GO:0060900 | embryonic camera-type eye formation | 1.214357e-2 |
GO:0010799 | regulation of peptidyl-threonine phosphorylation | 1.214357e-2 |
GO:0006281 | DNA repair | 1.217114e-2 |
GO:0060046 | regulation of acrosome reaction | 1.238314e-2 |
GO:0034447 | very-low-density lipoprotein particle clearance | 1.238314e-2 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 1.246604e-2 |
GO:0060806 | negative regulation of cell differentiation involved in embryonic placenta development | 1.246604e-2 |
GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity | 1.246604e-2 |
GO:0006930 | substrate-dependent cell migration, cell extension | 1.246604e-2 |
GO:0018364 | peptidyl-glutamine methylation | 1.246604e-2 |
GO:0032691 | negative regulation of interleukin-1 beta production | 1.252455e-2 |
GO:0051764 | actin crosslink formation | 1.261017e-2 |
GO:0000255 | allantoin metabolic process | 1.261017e-2 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 1.272010e-2 |
GO:0031069 | hair follicle morphogenesis | 1.288344e-2 |
GO:0032743 | positive regulation of interleukin-2 production | 1.294218e-2 |
GO:2000406 | positive regulation of T cell migration | 1.311871e-2 |
GO:0043299 | leukocyte degranulation | 1.321322e-2 |
GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep | 1.323807e-2 |
GO:0060272 | embryonic skeletal joint morphogenesis | 1.324672e-2 |
GO:0002676 | regulation of chronic inflammatory response | 1.325595e-2 |
GO:0002691 | regulation of cellular extravasation | 1.340549e-2 |
GO:0072161 | mesenchymal cell differentiation involved in kidney development | 1.344559e-2 |
GO:0032984 | macromolecular complex disassembly | 1.356863e-2 |
GO:0055007 | cardiac muscle cell differentiation | 1.363165e-2 |
GO:0030719 | P granule organization | 1.384645e-2 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | 1.406981e-2 |
GO:0009074 | aromatic amino acid family catabolic process | 1.419094e-2 |
GO:0034661 | ncRNA catabolic process | 1.442685e-2 |
GO:0009744 | response to sucrose stimulus | 1.442685e-2 |
GO:0015817 | histidine transport | 1.449348e-2 |
GO:0048668 | collateral sprouting | 1.449348e-2 |
GO:0019322 | pentose biosynthetic process | 1.449348e-2 |
GO:0046544 | development of secondary male sexual characteristics | 1.450657e-2 |
GO:0051013 | microtubule severing | 1.450657e-2 |
GO:0034214 | protein hexamerization | 1.450657e-2 |
GO:0033625 | positive regulation of integrin activation | 1.450657e-2 |
GO:0070672 | response to interleukin-15 | 1.451848e-2 |
GO:0060648 | mammary gland bud morphogenesis | 1.451848e-2 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.451848e-2 |
GO:0045065 | cytotoxic T cell differentiation | 1.451848e-2 |
GO:0030101 | natural killer cell activation | 1.453080e-2 |
GO:0048293 | regulation of isotype switching to IgE isotypes | 1.465049e-2 |
GO:0060081 | membrane hyperpolarization | 1.476167e-2 |
GO:0006897 | endocytosis | 1.488221e-2 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 1.500725e-2 |
GO:0045736 | negative regulation of cyclin-dependent protein kinase activity | 1.511575e-2 |
GO:0000245 | spliceosome assembly | 1.515524e-2 |
GO:0006302 | double-strand break repair | 1.524079e-2 |
GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 1.531715e-2 |
GO:0006376 | mRNA splice site selection | 1.554719e-2 |
GO:0072195 | kidney smooth muscle cell differentiation | 1.576385e-2 |
GO:0072105 | ureteric peristalsis | 1.576385e-2 |
GO:0072530 | purine-containing compound transmembrane transport | 1.586011e-2 |
GO:0070371 | ERK1 and ERK2 cascade | 1.586011e-2 |
GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation | 1.606771e-2 |
GO:0015931 | nucleobase-containing compound transport | 1.617598e-2 |
GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway | 1.618408e-2 |
GO:0043309 | regulation of eosinophil degranulation | 1.643034e-2 |